Open-label trial

Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa

Khavinson V, Razumovsky M, Trofimova S, et al. Neuro Endocrinology Letters 2002;23:365-368.

What it found

In rats with inherited retinal degeneration, epitalon was followed by better retinal electrical activity and structure. In patients with degenerative retinal disease, the authors reported a positive clinical effect in 90% of cases.

Limitations

PubMed indexes it as a controlled trial, but the abstract gives no patient numbers, control details or outcome measures. Single group; not independently replicated.

Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.